Practical guides, analyses and best practices for pharmaceutical cleaning validation teams.
The pharma industry drowns in regulatory documentation. Ring (A3P + Aktehom + Mindexia) lets you query 1,700+ life science referentials in plain language. Concrete use cases in cleaning validation.
MACO by therapeutic dose, HBEL/PDE or 10 ppm rule: the 3 formulas detailed with regulatory history, worked examples, and why the LD50 approach is prohibited.
The matrix approach groups similar entities rather than validating each product-equipment combination. Promising, it can also become a source of risk if poorly constructed.
When HBEL values are not available, Occupational Exposure Bands (OEB) offer a quick and consistent alternative for scoring toxicity.
Direct sampling by swab or indirect by rinsing? The two methods work on different principles and provide distinct information. Full comparison.
Calculating acceptance thresholds is not that complicated, but several parameters can be adjusted to bring them closer to production reality.
20 to 30% of deviations noted during GMP inspections concern cleaning validation. What auditors expect and how to avoid classic pitfalls.
MACO, ARL, PDE, LOD/LOQ, recovery rate… Each term has important implications for patient safety, regulatory compliance and risk management.
In a multi-product environment, the number of product A in B combinations can explode. Here is how to approach this challenge without losing the regulatory thread.
Annex 15, FDA 21 CFR Part 211, PDA TR 29 & 49… Do you really know all the documents that govern the validation of cleaning processes?
The worst-case approach rests on a simple principle: if it works for the hardest, it works for the rest. But in practice, choosing the worst-case product is fraught with pitfalls not to be underestimated.